Oscar Health, Inc.
General ticker "OSCR" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $4.0B (TTM average)
Oscar Health, Inc. follows the US Stock Market performance with the rate: 39.9%.
Estimated limits based on current volatility of 3.7%: low 16.66$, high 17.94$
Factors to consider:
- Total employees count: 2400 as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Changes to ACA regulations, Cybersecurity threats, Regulatory and compliance, Medical cost management, Customer retention
- Current price 40.8% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.21$, 14.75$]
- 2025-12-31 to 2026-12-31 estimated range: [5.65$, 11.76$]
Financial Metrics affecting the OSCR estimates:
- Positive: with PPE of -683.2 at the end of fiscal year the price was low
- Positive: -5.02 < Operating profit margin, % of 0.36
- Positive: Operating cash flow per share per price, % of 29.78 > 12.91
- Positive: 19.35 < Shareholder equity ratio, % of 20.94 <= 42.53
- Negative: Industry operating cash flow per share per price (median), % of 4.26 <= 5.42
- Negative: -0.76 < Inventory ratio change, % of 0
- Positive: Industry earnings per price (median), % of 5.51 > 4.45
- Negative: 0.01 < Interest expense per share per price, % of 0.72
- Positive: -3.57 < Return on assets ratio (scaled to [-100,100]) of 0.54
Short-term OSCR quotes
Long-term OSCR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $4,125.58MM | $5,862.87MM | $9,177.94MM |
| Operating Expenses | $4,735.66MM | $6,130.17MM | $9,144.51MM |
| Operating Income | $-610.08MM | $-267.30MM | $33.43MM |
| Interest Expense | $22.62MM | $24.60MM | $23.73MM |
| Income(Loss) | $-610.08MM | $-267.30MM | $33.43MM |
| Taxes | $-0.52MM | $3.29MM | $7.30MM |
| Profit(Loss)* | $-606.27MM | $-270.73MM | $25.43MM |
| Stockholders Equity | $890.38MM | $803.97MM | $1,013.59MM |
| Assets | $4,526.60MM | $3,601.48MM | $4,840.50MM |
| Operating Cash Flow | $380.35MM | $-272.16MM | $978.19MM |
| Capital expenditure | $29.01MM | $25.58MM | $27.90MM |
| Investing Cash Flow | $-226.52MM | $577.19MM | $-1,387.43MM |
| Financing Cash Flow | $301.11MM | $6.45MM | $68.39MM |
| Earnings Per Share** | $-2.85 | $-1.22 | $0.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.